Chronic consumption of a low-fat diet improves cardiometabolic risk factors according to the CLOCK gene in patients with coronary heart disease

Molecular Nutrition and Food Research

Volumn 59, Issue 12, 2015, Pages 2556-2564

  Gomez Delgado, Francisco ^a,b   Garcia Rios, Antonio ^a,b   Alcala Diaz, Juan Francisco ^a,b   Rangel Zuñiga, Oriol ^a,b   Delgado Lista, Javier ^a,b   Yubero Serrano, Elena M ^a,b   Lopez Moreno, Javier ^a,b   Tinahones, Francisco Jose ^b,c   Ordovas, Jose M ^d   Garaulet, Marta ^e   Lopez Miranda, Jose ^a,b   Perez Martinez, Pablo ^a,b  

^a HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^b Instituto de Salud Carlos III   (Spain)

^c HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

^d TUFTS UNIVERSITY   (United States)

^e UNIVERSITY OF MURCIA   (Spain)

Author keywords

CLOCK gene; CORDIOPREV clinical trial; Coronary heart disease; Gene diet interaction; Lipid metabolism

Indexed keywords

CLOCK PROTEIN, HUMAN; OLIVE OIL; TRANSCRIPTION FACTOR CLOCK;

CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIET THERAPY; FEMALE; GENETICS; HUMAN; LIPID METABOLISM; LOW FAT DIET; MALE; MEDITERRANEAN DIET; METABOLISM; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

CLOCK PROTEINS; CORONARY ARTERY DISEASE; DIET, FAT-RESTRICTED; DIET, MEDITERRANEAN; FEMALE; HUMANS; LIPID METABOLISM; MALE; MIDDLE AGED; OLIVE OIL; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84949314948     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201500375     Document Type: Article

References (43)

1. Go, A. S., Mozaffarian, D., Roger, V. L., Benjamin, E. J. et al., Heart disease and stroke statistics-2014 update: a report from the American Heart Association. Circulation 2014, 129, e28-e292.
2. Briffa, T. G., Hobbs, M. S., Tonkin, A., Sanfilippo, F. M. et al., Population trends of recurrent coronary heart disease event rates remain high. Circ. Cardiovasc. Qual. Outcomes 2011, 4, 107-113.
3. Yang, Q., Cogswell, M. E., Flanders, W. D., Hong, Y. et al., Trends in cardiovascular health metrics and associations with all-cause and CVD mortality among US adults. JAMA 2012, 307, 1273-1283.
4. Parsons, M. J., Moffitt, T. E., Gregory, A. M., Goldman-Mellor, S. et al., Social jetlag, obesity and metabolic disorder: investigation in a cohort study. Int. J. Obes. (Lond). 2015, 39, 842-848.
5. Dashti, H. S., Follis, J. L., Smith, C. E., Tanaka, T. et al., Habitual sleep duration is associated with BMI and macronutrient intake and may be modified by CLOCK genetic variants. Am. J. Clin. Nutr. 2015, 101, 135-143.
6. Garaulet, M., Gomez-Abellan, P., Alburquerque-Bejar, J. J., Lee, Y. C. et al., Timing of food intake predicts weight loss effectiveness. Int. J. Obes. 2013, 37, 604-611.
7. Garaulet, M., Gomez-Abellan, P., Timing of food intake and obesity: a novel association. Physiol. Behav. 2014, 134, 44-50.
8. Maury, E., Hong, H. K., Bass, J., Circadian disruption in the pathogenesis of metabolic syndrome. Diabetes Metab. 2014, 40, 338-346.
9. Scott, E. M., Carter, A. M., Grant, P. J., Association between polymorphisms in the Clock gene, obesity and the metabolic syndrome in man. Int. J. Obes. 2008, 32, 658-662.
10. Garaulet, M., Esteban Tardido, A., Lee, Y. C., Smith, C. E. et al., SIRT1 and CLOCK 3111T>C combined genotype is associated with evening preference and weight loss resistance in a behavioral therapy treatment for obesity. Int. J. Obes. 2012, 36, 1436-1441.
11. Sookoian, S., Gemma, C., Gianotti, T. F., Burgueno, A. et al., Genetic variants of Clock transcription factor are associated with individual susceptibility to obesity. Am. J. Clin. Nutr. 2008, 87, 1606-1615.
12. Garaulet, M., Lee, Y. C., Shen, J., Parnell, L. D. et al., CLOCK genetic variation and metabolic syndrome risk: modulation by monounsaturated fatty acids. Am. J. Clin. Nutr. 2009, 90, 1466-1475.
13. Garcia-Rios, A., Perez-Martinez, P., Delgado-Lista, J., Phillips, C. M. et al., A Period 2 genetic variant interacts with plasma SFA to modify plasma lipid concentrations in adults with metabolic syndrome. J. Nutr. 2012, 142, 1213-1218.
14. Portaluppi, F., Smolensky, M. H., Touitou, Y., Ethics and methods for biological rhythm research on animals and human beings. Chronobiol. Int. 2010, 27, 1911-1929.
15. Alcala-Diaz, J. F., Delgado-Lista, J., Perez-Martinez, P., Garcia-Rios, A. et al., Hypertriglyceridemia influences the degree of postprandial lipemic response in patients with metabolic syndrome and coronary artery disease: from the CORDIOPREV study. PLoS One 2014, 9, e96297.
16. Fernandez-Ballart, J. D., Pinol, J. L., Zazpe, I., Corella, D. et al., Relative validity of a semi-quantitative food-frequency questionnaire in an elderly Mediterranean population of Spain. Br. J. Nutr. 2010, 103, 1808-1816.
17. Martinez-Gonzalez, M. A., Fernandez-Jarne, E., Serrano-Martinez, M., Marti, A. et al., Mediterranean diet and reduction in the risk of a first acute myocardial infarction: an operational healthy dietary score. Eur. J. Nutr. 2002, 41, 153-160.
18. Estruch, R., Ros, E., Salas-Salvado, J., Covas, M. I. et al., Primary prevention of cardiovascular disease with a Mediterranean diet. N. Engl. J. Med. 2013, 368, 1279-1290.
19. Lichtenstein, A. H., Appel, L. J., Brands, M., Carnethon, M. et al., Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee. Circulation 2006, 114, 82-96.
20. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002, 106, 3143-3421.
21. Mazer, N. A., Giulianini, F., Paynter, N. P., Jordan, P. et al., Comparison of the theoretical relationship between HDL size and the ratio of HDL cholesterol to apolipoprotein A-I with experimental results from the Women's Health Study. Clin. Chem. 2013, 59, 949-958.
22. Miller, N. E., Associations of high-density lipoprotein subclasses and apolipoproteins with ischemic heart disease and coronary atherosclerosis. Am. Heart. J. 1987, 113, 589-597.
23. Mora, S., Otvos, J. D., Rifai, N., Rosenson, R. S. et al., Lipoprotein particle profiles by nuclear magnetic resonance compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women. Circulation 2009, 119, 931-939.
24. Mani, P., Uno, K., St John, J., Tuzcu, E. M. et al., Relation of high-density lipoprotein cholesterol:apolipoprotein a-I ratio to progression of coronary atherosclerosis in statin-treated patients. Am. J. Cardiol. 2014, 114, 681-685.
25. Friedewald, W. T., Levy, R. I., Fredrickson, D. S., Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 1972, 18, 499-502.
26. Wright, K. P., Jr., Drake, A. L., Frey, D. J., Fleshner, M. et al., Influence of sleep deprivation and circadian misalignment on cortisol, inflammatory markers, and cytokine balance. Brain Behav. Immun. 2015, 47, 24-34.
27. Leproult, R., Holmback, U., Van Cauter, E., Circadian misalignment augments markers of insulin resistance and inflammation, independently of sleep loss. Diabetes 2014, 63, 1860-1869.
28. Arroyo-Espliguero, R., Avanzas, P., Cosin-Sales, J., Aldama, G. et al., C-reactive protein elevation and disease activity in patients with coronary artery disease. Eur. Heart J. 2004, 25, 401-408.
29. Buckley, D. I., Fu, R., Freeman, M., Rogers, K. et al., C-reactive protein as a risk factor for coronary heart disease: a systematic review and meta-analyses for the U.S. Preventive Services Task Force. Ann. Intern. Med. 2009, 151, 483-495.
30. Sabatine, M. S., Morrow, D. A., de Lemos, J. A., Gibson, C. M. et al., Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide. Circulation 2002, 105, 1760-1763.
31. Ridker, P. M., Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 2003, 107, 363-369.
32. Sabatine, M. S., Morrow, D. A., Jablonski, K. A., Rice, M. M. et al., Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease. Circulation 2007, 115, 1528-1536.
33. Rader, D. J., Hovingh, G. K., HDL and cardiovascular disease. Lancet 2014, 384, 618-625.
34. Barylski, M., Toth, P. P., Nikolic, D., Banach, M. et al., Emerging therapies for raising high-density lipoprotein cholesterol (HDL-C) and augmenting HDL particle functionality. Best Pract. Res. Clin. Endocrinol. Metab. 2014, 28, 453-461.
35. Rohatgi, A., Khera, A., Berry, J. D., Givens, E. G. et al., HDL cholesterol efflux capacity and incident cardiovascular events. N. Engl. J. Med. 2014, 371, 2383-2393.
36. Superko, H. R., Pendyala, L., Williams, P. T., Momary, K. M. et al., High-density lipoprotein subclasses and their relationship to cardiovascular disease. J. Clin. Lipidol. 2012, 6, 496-523.
37. Rizzo, M., Otvos, J., Nikolic, D., Montalto, G. et al., Subfractions and subpopulations of HDL: an update. Curr. Med. Chem. 2014, 21, 2881-2891.
38. Li, X. L., Li, J. J., Guo, Y. L., Zhu, C. G. et al., The ratio of high-density lipoprotein cholesterol to apolipoprotein A-I predicts myocardial injury following elective percutaneous coronary intervention. Clin. Cardiol. 2014, 37, 558-565.
39. Paynter, N. P., Sesso, H. D., Conen, D., Otvos, J. D. et al., Lipoprotein subclass abnormalities and incident hypertension in initially healthy women. Clin. Chem. 2011, 57, 1178-1187.
40. Waldman, B., Jenkins, A. J., Davis, T. M., Taskinen, M. R. et al., HDL-C and HDL-C/ApoA-I predict long-term progression of glycemia in established type 2 diabetes. Diabetes Care 2014, 37, 2351-2358.
41. Brunham, L. R., Hayden, M. R., Human genetics of HDL: Insight into particle metabolism and function. Prog. Lipid Res. 2015, 58, 14-25.
42. Badellino, K. O., Wolfe, M. L., Reilly, M. P., Rader, D. J., Endothelial lipase is increased in vivo by inflammation in humans. Circulation 2008, 117, 678-685.
43. Perez-Martinez, P., Garcia-Rios, A., Delgado-Lista, J., Perez-Jimenez, F. et al., Metabolic syndrome: evidences for a personalized nutrition. Mol. Nutr. Food Res. 2012, 56, 67-76.